Literature DB >> 11230321

Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring.

P Manunta1, B P Hamilton, J M Hamlyn.   

Abstract

Elevated levels of an endogenous ouabain circulate in many patients with essential hypertension. However, in contrast to ouabain, digoxin does not induce hypertension. This study investigated the hypothesis that within a single cardiac glycoside, the structural elements that induce hypertension differ from those responsible for high potency as a sodium pump inhibitor. Normal male Sprague-Dawley rats received infusions of vehicle (VEH), rhamnose (RHA), ouabain (OUA), ouabagenin (OGN), dihydro-ouabain (DHO), iso-ouabain (ISO), and a lactone ring opened analog (ORO) at 30 microgram. kg(-1). 24 h(-1) for 5 weeks via subcutaneous osmotic pumps. Cuff pressures were taken weekly. At the end of the study, trunk blood was harvested, extracted by C18 column, and subjected to high-performance liquid chromatography. Fractions were analyzed for OUA, OGN, and DHO by immunoassay. In OUA-, OGN-, and DHO-infused rats, 1 main peak of immunoreactivity corresponding to the infused agent was found. No evidence of in vivo conversion to OUA or DHO was found for any analog except ORO. At 5 weeks, systolic blood pressures in VEH, RHA, OUA, OGN, DHO, ISO, and ORO were 132+/-2.5, 133+/-1.5, 159+/-2.6,* 154+/-4,* 167+/-4,* 171+/-2.2,* and 169+/-2.4* mm Hg, respectively (*P<0.01 versus VEH and RHA, P<0.05 versus OUA). The hypertensinogenic activity was greater than OUA in 3 analogs (DHO, ISO, and ORO) in which the lactone was saturated, conformationally restrained by linkage with the oxygen at C14, or opened, respectively. These compounds were weak inhibitors of dog kidney Na,K-ATPase. Thus, RHA and the unsaturated lactone ring are crucial to the high potency of OUA as an inhibitor of the sodium pump but appear to be unrelated to its ability to induce hypertension. The conclusion that this form of hypertension is mediated primarily by the steroid nucleus suggests also that OUA may have a mechanism of action independent of the sodium pump.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230321     DOI: 10.1161/01.hyp.37.2.472

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

1.  Selectivity of digitalis glycosides for isoforms of human Na,K-ATPase.

Authors:  Adriana Katz; Yael Lifshitz; Elizabeta Bab-Dinitz; Einat Kapri-Pardes; Rivka Goldshleger; Daniel M Tal; Steven J D Karlish
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

Review 2.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

Review 3.  Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.

Authors:  Mordecai P Blaustein; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-06

Review 4.  The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system.

Authors:  Mordecai P Blaustein
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-07       Impact factor: 4.249

5.  Ouabain-induced alterations in ABCB1 of mesenteric lymph nodes and thymocytes of rats and mice.

Authors:  Daniel Boff Lima; Raphael Carmo Valente; Marcia Alves Marques Capella
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

Review 6.  Endogenous ouabain in renal Na(+) handling and related diseases.

Authors:  Paolo Manunta; Elisabetta Messaggio; Nunzia Casamassima; Guido Gatti; Simona Delli Carpini; Laura Zagato; John M Hamlyn
Journal:  Biochim Biophys Acta       Date:  2010-03-11

7.  Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice.

Authors:  Jin Zhang; Moo Yeol Lee; Maurizio Cavalli; Ling Chen; Roberto Berra-Romani; C William Balke; Giuseppe Bianchi; Patrizia Ferrari; John M Hamlyn; Takahiro Iwamoto; Jerry B Lingrel; Donald R Matteson; W Gil Wier; Mordecai P Blaustein
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

8.  Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain.

Authors:  Fabiano E Xavier; Alvaro Yogi; Gláucia E Callera; Rita C Tostes; Yolanda Alvarez; Mercedes Salaices; María J Alonso; Luciana V Rossoni
Journal:  Br J Pharmacol       Date:  2004-10-11       Impact factor: 8.739

9.  Ouabain-digoxin antagonism in rat arteries and neurones.

Authors:  Hong Song; Eiji Karashima; John M Hamlyn; Mordecai P Blaustein
Journal:  J Physiol       Date:  2013-12-16       Impact factor: 5.182

10.  Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries.

Authors:  Fabiano E Xavier; Luciana V Rossoni; María J Alonso; Gloria Balfagón; Dalton V Vassallo; Mercedes Salaices
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.